AU2005324794C1 - Somatostatin analogue formulations - Google Patents
Somatostatin analogue formulations Download PDFInfo
- Publication number
- AU2005324794C1 AU2005324794C1 AU2005324794A AU2005324794A AU2005324794C1 AU 2005324794 C1 AU2005324794 C1 AU 2005324794C1 AU 2005324794 A AU2005324794 A AU 2005324794A AU 2005324794 A AU2005324794 A AU 2005324794A AU 2005324794 C1 AU2005324794 C1 AU 2005324794C1
- Authority
- AU
- Australia
- Prior art keywords
- administration
- formulation
- octreotide
- injection
- tumours
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/31—Somatostatins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Dispersion Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Obesity (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Child & Adolescent Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0326074.2 | 2003-11-07 | ||
GB0326075.9 | 2003-11-07 | ||
GB0412544.9 | 2004-06-04 | ||
GB0500807.3 | 2005-01-14 | ||
GB0500807A GB0500807D0 (en) | 2005-01-14 | 2005-01-14 | Formulation |
GB0507811.8 | 2005-04-18 | ||
GB0507811A GB0507811D0 (en) | 2005-04-18 | 2005-04-18 | Formulation |
PCT/GB2005/002217 WO2005117830A1 (fr) | 2004-06-04 | 2005-06-06 | Formulations de depot lipidique |
AUPCT/GB2005/002217 | 2005-06-06 | ||
GB0518878A GB0518878D0 (en) | 2005-09-15 | 2005-09-15 | Formulations |
GB0518878.4 | 2005-09-15 | ||
PCT/GB2005/004748 WO2006075124A1 (fr) | 2005-01-14 | 2005-12-09 | Formulations à base d'analogues de somatostatine |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2004/004696 Division WO2005046642A1 (fr) | 2003-11-07 | 2004-11-05 | Compositions de lipides et de peptides cationiques |
Publications (3)
Publication Number | Publication Date |
---|---|
AU2005324794A1 AU2005324794A1 (en) | 2006-07-20 |
AU2005324794B2 AU2005324794B2 (en) | 2010-05-13 |
AU2005324794C1 true AU2005324794C1 (en) | 2010-12-02 |
Family
ID=35986077
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2005324794A Active AU2005324794C1 (en) | 2003-11-07 | 2005-12-09 | Somatostatin analogue formulations |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1843746B1 (fr) |
JP (1) | JP5171262B2 (fr) |
KR (1) | KR100983746B1 (fr) |
AU (1) | AU2005324794C1 (fr) |
CA (1) | CA2594711C (fr) |
PL (1) | PL1843746T3 (fr) |
WO (1) | WO2006075124A1 (fr) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9649382B2 (en) | 2005-01-14 | 2017-05-16 | Camurus Ab | Topical bioadhesive formulations |
DE602005026998D1 (de) | 2005-01-14 | 2011-04-28 | Camurus Ab | Somatostatin-analog-formulierungen |
ES2343641T3 (es) | 2005-01-14 | 2010-08-05 | Camurus Ab | Formulaciones bioadhesivas topicas. |
EP1843751B1 (fr) | 2005-01-21 | 2020-09-30 | Camurus Ab | Compositions lipidiques pharmaceutiques |
DK1888031T3 (da) | 2005-06-06 | 2013-02-18 | Camurus Ab | GLP-1-analogformuleringer |
AU2015227534B2 (en) * | 2007-06-15 | 2017-02-23 | Camurus Ab | Peptide slow-release formulations |
AU2012202338B2 (en) * | 2007-06-15 | 2015-07-09 | Camurus Ab | Peptide slow-release formulations |
GB0711656D0 (en) * | 2007-06-15 | 2007-07-25 | Camurus Ab | Formulations |
GB0716385D0 (en) | 2007-08-22 | 2007-10-03 | Camurus Ab | Formulations |
EP2052716B1 (fr) * | 2007-10-24 | 2014-12-31 | Camurus AB | Formulations à libération contrôlée |
KR100998175B1 (ko) | 2008-05-30 | 2010-12-03 | 애니젠 주식회사 | 소마토스타틴의 제조방법 |
GB0815435D0 (en) | 2008-08-22 | 2008-10-01 | Camurus Ab | Formulations |
CA2755436C (fr) | 2009-03-19 | 2019-10-29 | Claude Carelli | Peptides destines a inhiber l'igf-1 |
TWI624271B (zh) * | 2011-05-25 | 2018-05-21 | 凱慕路斯公司 | 包含低黏度混合物之預調配物及其形成方法,及該低黏度混合物或預調配物之用途 |
KR101494594B1 (ko) * | 2011-08-30 | 2015-02-23 | 주식회사 종근당 | 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물 |
BR112014013693B1 (pt) * | 2011-12-05 | 2023-01-31 | Camurus Ab | Pré-formulação, e, uso de uma pré-formulação |
TW201336526A (zh) * | 2012-01-31 | 2013-09-16 | 參天製藥股份有限公司 | 非水性液體組成物 |
MX350964B (es) * | 2012-05-25 | 2017-09-27 | Camurus Ab | Formulaciones de agonistas del receptor de somatostatina. |
KR101586790B1 (ko) | 2012-12-28 | 2016-01-19 | 주식회사 종근당 | 음이온성 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물 |
KR101586791B1 (ko) | 2012-12-28 | 2016-01-19 | 주식회사 종근당 | GnRH 유도체의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물 |
KR101586789B1 (ko) | 2012-12-28 | 2016-01-19 | 주식회사 종근당 | 양이온성 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물 |
EP2823808A1 (fr) * | 2013-07-09 | 2015-01-14 | Ipsen Pharma S.A.S. | Composition pharmaceutique de lanréotide à libération prolongée |
CN109789215B (zh) | 2016-09-27 | 2022-12-16 | 卡姆拉斯公司 | 含有生长激素抑制素受体激动剂的制剂 |
EP3421485A1 (fr) | 2017-06-30 | 2019-01-02 | Université de Strasbourg | Anticorps pour la prévention et le traitement de la thrombose |
EP3437651A1 (fr) | 2017-08-03 | 2019-02-06 | Université de Strasbourg | Peptides pour le traitement et la prévention de la stéatose hépatique non alcoolique |
IL275188B2 (en) | 2017-12-14 | 2024-03-01 | Univ Strasbourg | Use of cyclic tripeptide to improve cellular energy metabolism |
IL284029B2 (en) | 2018-12-21 | 2023-09-01 | Univ Strasbourg | Peptides for the treatment and prevention of diabetes and related disorders |
JP2021059680A (ja) * | 2019-10-08 | 2021-04-15 | 花王株式会社 | 液晶組成物 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5807573A (en) * | 1994-06-15 | 1998-09-15 | Gs Development Ab | Lipid based composition containing diacylglycerol, phospholipid, polar liquid and biologically active material |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0643620B1 (fr) * | 1991-10-04 | 1999-07-21 | Gs Development Ab | Particules, procede de preparation desdites particules et utilisations |
WO1993006921A1 (fr) * | 1991-10-04 | 1993-04-15 | Gs Biochem Ab | Particules, procede de preparation desdites particules et utilisations |
CA2231273A1 (fr) * | 1995-10-12 | 1997-04-17 | Lise Sylvest Nielsen | Composition pharmaceutique pour l'administration d'un principe actif sur ou au travers d'une surface cutanee ou muqueuse |
CA2286052A1 (fr) * | 1997-04-17 | 1998-10-29 | Lise Sylvest Nielsen | Nouveau systeme bioadhesif d'administration de medicaments base sur des cristaux liquides |
BE1011899A6 (fr) * | 1998-04-30 | 2000-02-01 | Ucb Sa | Compositions pharmaceutiques gelifiables utilisables. |
WO2005046642A1 (fr) * | 2003-11-07 | 2005-05-26 | Camurus Ab | Compositions de lipides et de peptides cationiques |
US8182834B2 (en) * | 2004-01-23 | 2012-05-22 | Camurus Ab | Ternary non-lamellar lipid compositions |
-
2005
- 2005-12-09 PL PL05818366T patent/PL1843746T3/pl unknown
- 2005-12-09 AU AU2005324794A patent/AU2005324794C1/en active Active
- 2005-12-09 EP EP05818366A patent/EP1843746B1/fr active Active
- 2005-12-09 JP JP2007550826A patent/JP5171262B2/ja active Active
- 2005-12-09 KR KR1020077018617A patent/KR100983746B1/ko active IP Right Grant
- 2005-12-09 WO PCT/GB2005/004748 patent/WO2006075124A1/fr active Application Filing
- 2005-12-09 CA CA2594711A patent/CA2594711C/fr active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5807573A (en) * | 1994-06-15 | 1998-09-15 | Gs Development Ab | Lipid based composition containing diacylglycerol, phospholipid, polar liquid and biologically active material |
Also Published As
Publication number | Publication date |
---|---|
CA2594711C (fr) | 2012-11-06 |
WO2006075124A1 (fr) | 2006-07-20 |
AU2005324794B2 (en) | 2010-05-13 |
PL1843746T3 (pl) | 2011-09-30 |
JP5171262B2 (ja) | 2013-03-27 |
EP1843746B1 (fr) | 2011-03-16 |
AU2005324794A1 (en) | 2006-07-20 |
KR20070104599A (ko) | 2007-10-26 |
JP2008526933A (ja) | 2008-07-24 |
EP1843746A1 (fr) | 2007-10-17 |
CA2594711A1 (fr) | 2006-07-20 |
KR100983746B1 (ko) | 2010-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2005324794C1 (en) | Somatostatin analogue formulations | |
US20210268112A1 (en) | Peptide slow-release formulations | |
US8871712B2 (en) | Somatostatin analogue formulations | |
EP1888031B1 (fr) | Formulations d'analogues de glp-1 | |
JP6081479B2 (ja) | 頑強な徐放性ペプチド製剤 | |
JP6265888B2 (ja) | 制御放出ペプチド製剤 | |
WO2009024795A1 (fr) | Formulations lipidiques à teneur en acide | |
AU2015227534B2 (en) | Peptide slow-release formulations | |
AU2012202338B2 (en) | Peptide slow-release formulations | |
ES2363419T3 (es) | Formulaciones de análogos de somatostatina. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DA3 | Amendments made section 104 |
Free format text: THE NATURE OF THE AMENDMENT IS: ADD PRIORITY DETAILS UNDER INID (62) WO2005/046642 |
|
DA2 | Applications for amendment section 104 |
Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 07 JUN 2010. |
|
DA3 | Amendments made section 104 |
Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 07 JUN AND 22 JUL 2010 |
|
FGA | Letters patent sealed or granted (standard patent) |